New Delhi: In an effort to combat the incidence of cervical cancer in India, the government has announced plans to administer the human papillomavirus (HPV) vaccine to girls aged nine to 14 years in six states.
This first phase of the vaccination campaign is expected to target 2.55 crore girls in Karnataka, Tamil Nadu, Mizoram, Chhattisgarh, Maharashtra, and Uttar Pradesh, a PTI report cited. The Union Health Ministry plans to acquire 16.02 crore doses of the vaccine by 2026 and is preparing to tender a global call for bids in April.
The Serum Institute of India recently launched an indigenous HPV vaccine against cervical cancer called CERVAVAC. The Director of Government and Regulatory Affairs at the Serum Institute, Prakash Kumar Singh, wrote a letter to the Health Ministry saying that CERVAVAC will be available in the private market for ₹2,000 per dose in a two-dose glass vial presentation. Singh also pledged that the vaccine will be provided to the Health Ministry at an affordable price whenever it floats a tender. Currently, only one HPV vaccine, Gardasil, produced by American multinational Merck, is available in India’s private market for ₹10,850 in a single-dose pre-filled syringe presentation.
